Remote Field Application of Digital Technology for Hearing Assessments in a Cohort of Pediatric Germ Cell Tumor SurvivorsCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42024-06-130PRE
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I TrialCLINICAL CANCER RESEARCHIF10.22023-05-039OA
Special considerations in the design and implementation of pediatric otoprotection trialsJOURNAL OF CANCER SURVIVORSHIPIF2.92023-01-1310PRE
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort studyLANCET CHILD & ADOLESCENT HEALTHIF15.52021-04-0146OAAI
Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guidelineLANCET CHILD & ADOLESCENT HEALTHIF15.52020-02-0178OAAI
Interventions for cisplatin-induced hearing loss in children and adolescents with cancerLANCET CHILD & ADOLESCENT HEALTHIF15.52019-08-0136OAAI
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous systemCANCERIF5.12007-12-1045OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向